Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction
Sign Up to like & getrecommendations! Published in 2017 at "Case Reports in Medicine"
DOI: 10.1155/2017/4895736
Abstract: VIEKIRA PAK (ritonavir-boosted paritaprevir/ombitasvir and dasabuvir) is an approved treatment for compensated patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection. This oral regimen has minimal adverse effects and is well tolerated. Cure… read more here.
Keywords: chronic hepatitis; treatment; viekira pak; pak ... See more keywords